Agrupación Estratéxica en Materiais (AEMAT)
Agrupación estratéxica de I+D+i
French Institute of Health and Medical Research
París, FranciaPublicacións en colaboración con investigadores/as de French Institute of Health and Medical Research (11)
2024
-
A vitamin D-based strategy overcomes chemoresistance in prostate cancer
British Journal of Pharmacology, Vol. 181, Núm. 21, pp. 4279-4293
-
Developing an innovative 3D printing platform for production of personalised medicines in a hospital for the OPERA clinical trial
International Journal of Pharmaceutics, Vol. 661
-
Overlay databank unlocks data-driven analyses of biomolecules for all
Nature communications, Vol. 15, Núm. 1, pp. 1136
-
The 2024 Europe report of the Lancet Countdown on health and climate change: unprecedented warming demands unprecedented action
The Lancet Public Health, Vol. 9, Núm. 7, pp. e495-e522
2023
2021
-
Design, Synthesis, Evaluation and Structure of Allenic 1α,25-Dihydroxyvitamin D3 Analogs with Locked Mobility at C-17
Chemistry - A European Journal, Vol. 27, Núm. 53, pp. 13384-13389
-
Design, synthesis and evaluation of side-chain hydroxylated derivatives of lithocholic acid as potent agonists of the vitamin D receptor (VDR)
Bioorganic Chemistry, Vol. 115
-
Lithocholic acid-based design of noncalcemic vitamin D receptor agonists
Bioorganic Chemistry, Vol. 111
2016
-
Carborane-based design of a potent Vitamin D receptor agonist
Chemical Science, Vol. 7, Núm. 2, pp. 1033-1037
2008
-
Structure-Based Design of a Superagonist Ligand for the Vitamin D Nuclear Receptor
Chemistry and Biology, Vol. 15, Núm. 4, pp. 383-392
2007
-
Crystal structure of the vitamin D nuclear receptor ligand binding domain in complex with a locked side chain analog of calcitriol
Archives of Biochemistry and Biophysics, Vol. 460, Núm. 2, pp. 172-176